172 related articles for article (PubMed ID: 23344026)
1. A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells.
Lo YL
Int J Mol Sci; 2012 Dec; 14(1):158-76. PubMed ID: 23344026
[TBL] [Abstract][Full Text] [Related]
2. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
Lo YL; Wang W
Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
[TBL] [Abstract][Full Text] [Related]
3. 7,3',4'-Trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen species.
Lo YL; Wang W; Ho CT
Toxicology; 2012 Dec; 302(2-3):221-32. PubMed ID: 22914566
[TBL] [Abstract][Full Text] [Related]
4. Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.
Lo YL; Liu Y
PLoS One; 2014; 9(3):e90180. PubMed ID: 24637737
[TBL] [Abstract][Full Text] [Related]
5. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
Lo YL; Liu Y; Tsai JC
Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
Lee YK; Lin TH; Chang CF; Lo YL
PLoS One; 2013; 8(11):e82478. PubMed ID: 24303084
[TBL] [Abstract][Full Text] [Related]
7. Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells.
Lo YL; Tu WC
Chem Biol Interact; 2015 Dec; 242():13-23. PubMed ID: 26335193
[TBL] [Abstract][Full Text] [Related]
8. The Use of a Liposomal Formulation Incorporating an Antimicrobial Peptide from Tilapia as a New Adjuvant to Epirubicin in Human Squamous Cell Carcinoma and Pluripotent Testicular Embryonic Carcinoma Cells.
Lo YL; Lee HP; Tu WC
Int J Mol Sci; 2015 Sep; 16(9):22711-34. PubMed ID: 26393585
[TBL] [Abstract][Full Text] [Related]
9. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
Lo YL; Ho CT; Tsai FL
Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
[TBL] [Abstract][Full Text] [Related]
11. Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells.
Juang V; Lee HP; Lin AM; Lo YL
Int J Nanomedicine; 2016; 11():6047-6064. PubMed ID: 27895479
[TBL] [Abstract][Full Text] [Related]
12. Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells.
Šemeláková M; Jendželovský R; Fedoročko P
Biomed Pharmacother; 2016 Jul; 81():38-47. PubMed ID: 27261575
[TBL] [Abstract][Full Text] [Related]
13. Chalcone derivatives cause accumulation of colon cancer cells in the G2/M phase and induce apoptosis.
Kello M; Drutovic D; Pilatova MB; Tischlerova V; Perjesi P; Mojzis J
Life Sci; 2016 Apr; 150():32-8. PubMed ID: 26916824
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
15. Suppression of c-Myc is involved in multi-walled carbon nanotubes' down-regulation of ATP-binding cassette transporters in human colon adenocarcinoma cells.
Wang Z; Xu Y; Meng X; Watari F; Liu H; Chen X
Toxicol Appl Pharmacol; 2015 Jan; 282(1):42-51. PubMed ID: 25461681
[TBL] [Abstract][Full Text] [Related]
16. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells.
Šemeláková M; Mikeš J; Jendželovský R; Fedoročko P
J Photochem Photobiol B; 2012 Dec; 117():115-25. PubMed ID: 23099482
[TBL] [Abstract][Full Text] [Related]
17. Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline.
Felipe AV; Oliveira J; Moraes AA; França JP; Silva TD; Forones NM
Asian Pac J Cancer Prev; 2018 May; 19(5):1237-1242. PubMed ID: 29801407
[TBL] [Abstract][Full Text] [Related]
18. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
[TBL] [Abstract][Full Text] [Related]
19. Expression of ABC transporters in human hepatocyte carcinoma cells with cross-resistance to epirubicin and mitoxantrone.
Kamiyama N; Takagi S; Yamamoto C; Kudo T; Nakagawa T; Takahashi M; Nakanishi K; Takahashi H; Todo S; Iseki K
Anticancer Res; 2006; 26(2A):885-8. PubMed ID: 16619483
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid.
Lo YL; Liu FI; Yang JM; Cherng JY
Anticancer Res; 2001; 21(1A):445-50. PubMed ID: 11299776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]